Houlihan Capital advised Health Coalition, Inc. on its partnership with Provider Network Holdings, a Waud Capital Partners portfolio company.
Date: April 2024 Client: Health Coalition, Inc. Sector: Healthcare Industry: Specialty Distribution Houlihan Capital advised Health Coalition, Inc. (“Health Coalition”) on its partnership with Provider Network Holdings, a Waud Capital Partners portfolio company. Health Coalition is headquartered in Doral, FL and was founded in 1988 by Walter Shikany, Jr. The company partners with specialty pharmaceutical […]
U.S. Micro Middle Market – 2H 2023 Update
Houlihan Capital’s Investment Banking group specializes in providing sell-side M&A advisory services to owners of privately held businesses within the Micro Middle Market (“MMM”), which we define as those with total enterprise value (“TEV”) below $250M. We are pleased to announce the publication of our newest report, M&A Activity – U.S. Micro Middle Market Update […]
Houlihan Capital acted as the exclusive financial advisor on the sale of Choice Labs
Date: September 30, 2023 Client: Choice Labs Sale to: Glorious Cannabis Company Industry: Cannabis Houlihan Capital (Chicago, IL) acted as the exclusive financial advisor on the sale of Choice Labs Holding Co, LLC (“Choice Labs”) to multi-state operator, Glorious Cannabis Company. The transaction closed on September 30, 2023. Headquartered on a 10-acre campus in Jackson, […]
Jacques Zureikat will attend the 2024 ATSSA Convention & Traffic Expo
Jacques Zureikat, Vice President of Investment Banking, will be attending the 2024 ATSSA Convention & Traffic Expo from February 4 – 6 in San Diego, CA. For more information on this conference, please click HERE. Houlihan Capital’s investment banking group recently completed the sale of a pavement marking contractor in December 2023 (details below). Our […]
SEC Discusses Valuation Focus in 2024 Exam Priorities
The SEC discusses valuation in the Division of Examinations’ 2024 Exam Priorities. The SEC’s Division of Examinations (the “DOE”) has announced its 2024 examination priorities. The annual report provides insights into the Division’s risk-based approach, including the areas it believes present potential risks to investors and the integrity of U.S. capital markets(1). Valuation was discussed […]